Gao, Xue

Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

Hu, J. H., Miller, S. M., Geurts, M. H., Tang, W., Chen, L., Sun, N., Zeina, C. M., Gao, X., Rees, H. A., Lin, Z., et al. (2018) · Nature

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 1,552

Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles

Wang, M., Zuris, J. A., Meng, F., Rees, H., Sun, S., Deng, P., Han, Y., Gao, X., Pouli, D., Wu, Q., et al. (2016) · Proceedings of the National Academy of Sciences

RNA Interference and Gene DeliveryCRISPR and Genetic Engineering

Cited by 624

Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents

Gao, X., Tao, Y., Lamas, V., Huang, M., Yeh, W.-H., Pan, B., Hu, Y.-J., Hu, J. H., Thompson, D. B., Shu, Y., et al. (2018) · Nature

Hearing, Cochlea, Tinnitus, GeneticsCRISPR and Genetic Engineering

Cited by 536

Structural basis for the activation of a compact CRISPR-Cas13 nuclease

Deng, X., Osikpa, E., Yang, J., Oladeji, S. J., Smith, J., Gao, X., & Gao, Y. (2023) · Nature Communications

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 35

Recent advances in prime editing technologies and their promises for therapeutic applications

Zeng, H., Daniel, T. C., Lingineni, A., Chee, K., Talloo, K., & Gao, X. (2024) · Current Opinion in Biotechnology

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 27